Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism

被引:42
|
作者
Yang, Mingzheng [1 ]
Kan, Lin [2 ]
Wu, Lianye [1 ]
Zhu, Yingchun [1 ]
Wang, Qing [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Nephrol, 1158 Gongyuan East Rd, Shanghai 201700, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Qingpu Branch, Dept Clin Lab, Shanghai 201700, Peoples R China
关键词
baicalin; diabetic nephropathy; renal function; therapeutic mechanism; OXIDATIVE STRESS; DISEASE; CELLS; APOPTOSIS; INJURY; STAGE; VEGF;
D O I
10.3892/etm.2019.7181
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study observed the effect of baicalin on blood glucose and renal function in patients with diabetic nephropathy and explored its mechanism of action. A total of 95 patients diagnosed with diabetic nephropathy by clinical and laboratory examinations were selected and randomly divided into a control and treatment group. The control group included 45 patients who were treated with routine symptomatic treatment. The remaining 50 patients in the treatment group received baicalin, in addition to routine symptomatic treatment. The treatment course was 6 months. Following this, the changes of indicators such as fasting plasma glucose (FPG), glycosylated hemoglobin (HBA1c), aldose reductase (AR) activity, 24-h urinary microalbumin, urinary 2-microglobulin (2-MG) and urinary albumin excretion rate (UAER) were compared before and after treatment; at the same time, the variations of indexes, including superoxide dismutase (SOD), glutathione peroxidase (GSH-px), nuclear factor -light-chain-enhancer of activated B cells (NF-B), transforming growth factor-1 (TGF-1) and vascular endothelial growth factor (VEGF) were detected. Compared with those in the control group, baicalin had little effect on the treatment group's FPG and HBA1c, but it clearly reduced the AR activity and the difference was significant (P<0.05). Baicalin visibly decreased the 24-h urinary microalbumin, urinary 2-MG and UAER (P<0.05) and had notable effect on improving renal function. Following treatment, compared with those in the control group, baicalin distinctly increased the levels of SOD and GSH-px (P<0.05) and decreased the content of NF-B and VEGF (P<0.05), however, its impact on the expression of TGF-1 was not statistically significant (P>0.05). The results showed that baicalin may improve the renal function in patients with diabetic nephropathy and delay the progression of diabetic nephropathy through various ways, including anti-inflammation and anti-oxidation.
引用
收藏
页码:2071 / 2076
页数:6
相关论文
共 50 条
  • [21] The influence of pregnancy on renal function loss in insulin dependent diabetic patients with diabetic nephropathy
    Rossing, K
    Jacobsen, P
    Hommel, E
    Mathiesen, E
    Svenningsen, A
    Rossing, P
    Parving, HH
    DIABETOLOGIA, 1998, 41 : A8 - A8
  • [22] Prevention of loss of renal function over time in patients with diabetic nephropathy
    Barnett, A
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (05): : 40S - 47S
  • [23] Mechanism of the progression of diabetic nephropathy to renal failure
    Kikkawa, R
    Togawa, M
    Isono, M
    Isshiki, K
    Haneda, M
    KIDNEY INTERNATIONAL, 1997, 52 : S39 - S40
  • [24] CORRELATION OF VASCULAR ENDOTHELIAL FUNCTION AND INFLAMMATORY FACTORS WITH RENAL FUNCTION IN PATIENTS WITH DIABETIC NEPHROPATHY
    Mammadzada, A. Y.
    Ismayilova, Sh. G.
    Ibrahimova, Sh. S.
    Huseynova, N. I.
    Huseyn, L. A.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 85 (03): : 129 - 132
  • [25] Predicting the decline of renal function in diabetic nephropathy
    Plaetke, R
    Blaum, W
    Mohatt, G
    Abboud, H
    Pergola, P
    DIABETES, 2004, 53 : A506 - A506
  • [26] Autophagy and its therapeutic potential in diabetic nephropathy
    Han, Yu-Peng
    Liu, Li-Juan
    Yan, Jia-Lin
    Chen, Meng-Yuan
    Meng, Xiang-Fei
    Zhou, Xin-Ru
    Qian, Ling-Bo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [27] Effect of renal artery stenting on renal function in patients with ischemic nephropathy
    Ilkay, E
    Günal, AI
    Yavuzkir, M
    Dagli, N
    Karaca, I
    Celiker, H
    Dogukan, A
    Arslan, N
    JAPANESE HEART JOURNAL, 2004, 45 (04): : 637 - 645
  • [28] EFFECT OF HYPERCHOLESTEROLEMIA ON VASCULAR ENDOTHERIAL FUNCTION IN PATIENTS WITH DIABETIC NEPHROPATHY
    NAKANO, H
    YAMADA, K
    NISHIMURA, M
    MIURA, Y
    SUZUKI, S
    WAKABAYASHI, Y
    TUCHIDA, H
    SHIBASAKI, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 453 - 453
  • [29] Effect of febuxostat on renal function in patients from South China with CKD3 diabetic nephropathy
    Huang Wen
    Zhu Yongling
    Zheng Shuying
    Wang Jiali
    Zhao Yanling
    JORNAL BRASILEIRO DE NEFROLOGIA, 2020, 42 (04): : 393 - 399
  • [30] Estrogen ameliorates renal pathology and renal function in diabetic nephropathy
    Maric, C
    Bhatti, F
    Ratner, R
    Howard, B
    Sandberg, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 126A - 126A